文献速递心外重症与机械循环支持

儿童左心室辅助装置置入后肾功能变化:Pedimacs分析

Changes in renal function after left ventricular assist device placement in pediatric patients: A Pedimacs analysis.
PubMed 文献 · J Heart Lung Transplant · 2018-07-24

基于Pedimacs注册研究247例儿童LVAD患者,61%存在基线肾功能不全(eGFR<90 ml/min/1.73 m2)。LVAD置入后eGFR总体改善,1个月达峰值,基线eGFR越低改善越明显。1周肾功能未正常化与1个月持续肾功能不全相关,但置入前肾功能不影响移植存活。

要点

  • 儿童LVAD置入后肾功能总体改善,1个月达峰值。
  • 基线肾功能不全者改善更显著,不受年龄、诊断、INTERMACS分级或装置类型影响。
  • 1周肾功能未正常化与1个月持续肾功能不全相关。

核心结论

  • 儿童LVAD置入后肾功能改善,基线肾功能不全者改善最明显。
  • 置入前肾功能不影响移植存活。

研究设计与样本

  • 回顾性队列分析Pedimacs注册研究2012年9月19日至2016年6月30日 enrolled 的儿童LVAD recipient,共247例来自39个中心。
  • 采用纵向分析、Logistic回归和Kaplan-Meier法评估肾功能变化及 outcomes。

主要发现

  • 247例中150例(61%)存在基线肾功能不全(eGFR<90 ml/min/1.73 m2)。
  • eGFR总体在LVAD置入后改善,峰值在置入后1个月。
  • 基线eGFR与1个月改善程度呈负相关。
  • 1个月eGFR改善程度不受装置类型、年龄、INTERMACS分级或诊断影响。
  • 1周肾功能未正常化与1个月持续肾功能不全相关。

关键数值与推荐

  • 基线肾功能不全定义为eGFR<90 ml/min/1.73 m2。
  • 1个月eGFR改善程度不受装置类型、年龄、INTERMACS分级或诊断影响。
  • 按置入前肾功能分层,置入后 outcomes 无差异。

临床怎么用

  • 儿童LVAD置入后应监测肾功能,尤其基线肾功能不全者。
  • 1周肾功能未正常化者需警惕1个月持续肾功能不全。
  • 置入前肾功能不应作为排除LVAD的依据,因其不影响移植存活。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Renal dysfunction (RD) is prevalent among pediatric patients with advanced heart failure. Data are limited regarding changes in renal function after left ventricular assist device (LVAD) placement in this population. METHODS: Pediatric LVAD recipients enrolled in the Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) between September 19, 2012 and June 30, 2016 were included. Longitudinal changes in renal function were analyzed for the entire cohort as well as subgroups stratified by patient and device characteristics. Logistic regression was used to attempt to identify factors associated with lack of improvement in renal function after LVAD placement. Post-LVAD outcomes were assessed using the Kaplan‒Meier method. RESULTS: Data from 247 patients from 39 centers were analyzed. Baseline RD (estimated glomerular filtration rate [eGFR] <90 ml/min/1.73 m2) was present in 150 (61%) patients. Overall, eGFR improved post-LVAD, peaking at 1 month post-implant. There was an inverse relationship between baseline eGFR and the degree of improvement at 1 month. Degree of improvement in eGFR at 1 month was not impacted by device type, age, Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) profile, or diagnosis. Failure to normalize renal function at 1 week was correlated with persistent RD at 1 month. Post-implant outcomes did not differ among patients stratified by pre-implant renal function. CONCLUSIONS: Renal function improves post-LVAD placement in pediatric patients regardless of age, diagnosis, illness severity, or device type, with improvement most pronounced in patients with baseline RD. Identifying patients with irreversible renal dysfunction before LVAD placement remains difficult. Pre-LVAD renal function does not appear to impact survival to transplant.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Friedland-Little JM, Hong BJ, Gossett JG, et al. Changes in renal function after left ventricular assist device placement in pediatric patients: A Pedimacs analysis. J Heart Lung Transplant. 2018. PMID: 30293616. doi:10.1016/j.healun.2018.06.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。